Made for each other….Laboratoires Théa acquire The EyeBag® Brand
Laboratoires Théa – a French family-owned pharmaceutical company, specialising in eye care around the world are delighted to announce that they have acquired The EyeBag® brand.
The MGDRx EyeBag®, was launched 16 years ago by Prof. Teifi James, a consultant ophthalmologist, as a natural, effective treatment for dry eye, MGD, blepharitis and the symptoms associated with these conditions. It has been widely adopted by eye care professionals in the UK and fits perfectly into the range of products offered by Théa. “We are taking this new and exciting direction with Théa which will be good for our customers, our people, and the eye care sector,” commented Teifi James, MD, The EyeBag Co Ltd.
“This is an exciting addition to the Théa portfolio,” said Philip Lewis Williams, MD of Théa UK. “We have worked closely with Prof. James for a number of years, starting with the development of the Théa Dry Eye Project. The MGDRx EyeBag® is the missing piece in Théa’s Dry Eye and MGD portfolio. We are delighted that we can now offer a full range of products to patients and practitioners alike looking for a complete treatment of their Dry Eye. The products were simply made for each other.”
Laboratoires Théa’s research and development in the latest pharmacological treatments combined with its distribution network covering more than 70 countries, provides an ideal platform to introduce The EyeBag® to a global audience.
Whilst distribution transitions into the Théa network over the coming months, the product will continue to be available through your normal distributor or direct from the EyeBag sales team in Halifax.
Théa UK will inform all customers when the transition is complete and the MGDRx EyeBag® is available to be ordered through their own distribution channels.